Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines

BACKGROUND: Bronchial carcinoids are pulmonary neuroendocrine cell-derived tumors comprising typical (TC) and atypical (AC) malignant phenotypes. The 5-year survival rate in metastatic carcinoid, despite multiple current therapies, is 14-25%. Hence, we are testing novel therapies that can affect the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Mokhtari, Reza Bayat, Kumar, Sushil, Islam, Syed S, Yazdanpanah, Mehrdad, Adeli, Khosrow, Cutz, Ernest, Yeger, Herman
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2013
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3848757/
https://ncbi.nlm.nih.gov/pubmed/23927827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-378
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia